Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies

Cavid Baba,Sinem Ozcelik,Ergi Kaya,Ulvi Samedzada,Asiye Tuba Ozdogar,Sumeyye Cevik,Yavuz Dogan,Serkan Ozakbas

Multiple Sclerosis and Related Disorders（2022）

引用 3|浏览1

暂无评分

摘要

The study shows that even after inactivated vaccine schedule, mRNA still offers more protection in people with multiple sclerosis on disease-modifying therapies.

查看译文

关键词

Multiple sclerosis,COVID-19,Vaccination,Disease-modifying therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要